TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
Clinical trial NCT03741244 · UNKNOWN
Trial details
- NCT number
- NCT03741244
- Sponsor
- The Second Hospital of Hebei Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-06
- Primary completion
- 2022-10-01
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.